STOCK TITAN
  1. Home
  2. Sec-filings
  3. PRRUF
  4. [Form 3] IMMUTEP Ltd Initial Statement of Beneficial Ownership

IMMUTEP (IMMP) director Russell Howard details performance rights and indirect shareholdings in Form 3

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

IMMUTEP Ltd director Dr. Russell Howard has filed an initial Form 3 showing his equity interests in the company. The filing reports performance rights over 50,000 Ordinary Shares granted on November 23, 2023, which may vest on December 1, 2026 if vesting conditions are met. Additional performance rights granted on December 2, 2025 cover 400,154 Ordinary Shares scheduled to vest on December 1, 2026, and two further tranches of 461,746 performance rights each that may vest on December 1, 2027 and December 1, 2028, all subject to specified vesting conditions. The Form 3 also reports 1,717,977 Ordinary Shares held indirectly through Regulus Star Pty Ltd.

Positive

  • None.

Negative

  • None.
Insider HOWARD RUSSELL J
Role Director
Type Security Shares Price Value
holding Performance rights (right to receive) -- -- --
holding Performance rights (right to receive) -- -- --
holding Performance rights (right to receive) -- -- --
holding Performance rights (right to receive) -- -- --
holding Ordinary Shares -- -- --
Holdings After Transaction: Performance rights (right to receive) — 50,000 shares (Direct); Ordinary Shares — 1,717,977 shares (Indirect, By Regulus Star Pty Ltd)
Footnotes (1)
  1. Granted on November 23, 2023. 50,000 performance rights will vest on December 1, 2026, which is dependent on Dr. Howard meeting the vesting conditions. Granted on December 2, 2025. 400,154 performance rights will vest on December 1, 2026 and the vesting of the remaining 923,492 performance rights is dependent on Dr. Howard meeting the vesting conditions. Granted on December 2, 2025. 461,746 performance rights will vest on December 1, 2027 and the vesting of the remaining 461,746 performance rights is dependent on Dr. Howard meeting the vesting conditions. Granted on December 2, 2025. 461,746 performance rights will vest on December 1, 2028 and the vesting of the performance rights is dependent on Dr. Howard meeting the vesting conditions.
Performance rights tranche 1 50,000 performance rights Granted November 23, 2023; scheduled to vest December 1, 2026
Performance rights tranche 2 400,154 performance rights Granted December 2, 2025; scheduled to vest December 1, 2026
Performance rights tranche 3 461,746 performance rights Granted December 2, 2025; scheduled to vest December 1, 2027
Performance rights tranche 4 461,746 performance rights Granted December 2, 2025; scheduled to vest December 1, 2028
Indirect Ordinary Shares 1,717,977 Ordinary Shares Held indirectly by Regulus Star Pty Ltd
Performance rights exercise price $0.0000 per share Exercise price for reported performance rights over Ordinary Shares
Earliest performance rights expiration November 23, 2028 Expiration date for one performance rights grant
Latest performance rights expiration December 2, 2030 Expiration date for later performance rights grants
Performance rights financial
"Performance rights (right to receive) over IMMUTEP Ordinary Shares"
Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.
vesting conditions financial
"the vesting of the remaining performance rights is dependent on Dr. Howard meeting the vesting conditions"
Vesting conditions are the rules that determine when someone earning company stock or stock options actually gains the right to keep or sell them, typically based on staying with the company for a set time or meeting performance targets. Think of it like keys that unlock gradually — some unlock by calendar date, others only after agreed milestones. Investors care because vesting shapes management incentives, the timing of share sales, and the number of shares that can enter the market, which can affect a company's valuation and ownership mix.
Ordinary Shares financial
"underlying security title: Ordinary Shares"
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.
indirect ownership financial
"direct_or_indirect: I, nature_of_ownership: By Regulus Star Pty Ltd"
Understanding Insider Trading Forms →
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
HOWARD RUSSELL J
(Last)(First)(Middle)
LEVEL 32, AUSTRALIA SQUARE,
264 GEORGE STREET
(Street)
SYDNEY, NEW SOUTH WALESAUSTRALIA2000
(City)(State)(Zip)
AUSTRALIA
(Country)		2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026		3. Issuer Name and Ticker or Trading Symbol
IMMUTEP Ltd [ IMMP ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares1,717,977IBy Regulus Star Pty Ltd
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Performance rights (right to receive)(1)12/01/202611/23/2028Ordinary Shares50,000$0D
Performance rights (right to receive)(2)12/01/202612/02/2030Ordinary Shares400,154$0D
Performance rights (right to receive)(3)12/01/202712/02/2030Ordinary Shares461,746$0D
Performance rights (right to receive)(4)12/01/202812/02/2030Ordinary Shares461,746$0D
Explanation of Responses:
1. Granted on November 23, 2023. 50,000 performance rights will vest on December 1, 2026, which is dependent on Dr. Howard meeting the vesting conditions.
2. Granted on December 2, 2025. 400,154 performance rights will vest on December 1, 2026 and the vesting of the remaining 923,492 performance rights is dependent on Dr. Howard meeting the vesting conditions.
3. Granted on December 2, 2025. 461,746 performance rights will vest on December 1, 2027 and the vesting of the remaining 461,746 performance rights is dependent on Dr. Howard meeting the vesting conditions.
4. Granted on December 2, 2025. 461,746 performance rights will vest on December 1, 2028 and the vesting of the performance rights is dependent on Dr. Howard meeting the vesting conditions.
Russell John Howard04/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What does IMMUTEP (IMMP) director Russell Howard report on this Form 3?

The Form 3 reports Dr. Russell Howard’s initial beneficial ownership in IMMUTEP, including several tranches of performance rights over Ordinary Shares and indirectly held Ordinary Shares through Regulus Star Pty Ltd, outlining his existing equity-linked interests in the company.

How many IMMUTEP (IMMP) performance rights vest for Dr. Howard and when?

Dr. Howard holds 50,000 performance rights scheduled to vest on December 1, 2026, plus 400,154 performance rights also scheduled to vest on December 1, 2026, and two tranches of 461,746 performance rights each that may vest on December 1, 2027 and December 1, 2028.

Are Dr. Howard’s IMMUTEP (IMMP) performance rights subject to conditions?

Yes. Each performance right grant is subject to vesting conditions. The footnotes state that vesting of the various tranches, including the 50,000, 400,154 and 461,746 performance rights, depends on Dr. Howard meeting specified vesting conditions before the scheduled vesting dates.

What indirect IMMUTEP (IMMP) shareholding does Dr. Howard report?

The Form 3 reports that 1,717,977 Ordinary Shares of IMMUTEP are held indirectly “By Regulus Star Pty Ltd.” This indicates Dr. Howard’s beneficial interest is reported through that entity, rather than as directly held shares in his own name.

What are the exercise prices and expirations of IMMUTEP (IMMP) performance rights?

The performance rights reported for Dr. Howard have an exercise price of $0.0000 per underlying Ordinary Share. Expiration dates in the filing include November 23, 2028 and December 2, 2030, defining the latest dates by which rights remain outstanding.